Phosphagen. Share Discussion Threads

[spaceparallax] 10/8/2006 09:26

GCI article featured PSG, with some positive background info. The closing para - "I think the current 11p share price - valuing the business at £60M - is too low. Analysts at contract research house Equity Development agree, suggesting the shares could be worth as much as 41-50p. For me, PSG is a good speculative bet."

[cmp2] 09/8/2006 20:58

elfman, you get back to your wok....or you'll end up like jonny yen.

[elfman] 04/8/2006 09:42

Flint, you may be the one-eyed King, but I think cmp2 is a bit of a 'one-eyed trouser snake' ;0)

[cmp2] 03/8/2006 20:31

and flint, didn't we used to refer to you as the 'king' a few years back...around the same time as the 'elfman' was borne.
just remember who put you into this one...

and keep an eye on AT communications (ATCG) over the next few weeks. In at 47p.

[flintsurfer] 02/8/2006 23:09

Hey - Elfman - remember the old saying " In the land of the blind, the one eyed man is king"
I've got my eye on these! ;)
(BTW - I meant breakout from previous trading range -sure don't expect anything until proper news but a good sign nevertheless)

[elfman] 02/8/2006 13:27

Yeah you twit ;0)

[spaceparallax] 02/8/2006 13:23

Flint,

Things are certainly looking up, but I suspect that it's a little premature to expect a breakout. So much is dependant upon the current trials that are expected to be reported in September.

[flintsurfer] 02/8/2006 09:44

Dare I suggest the start of a breakout???!!
Volume up in Aus of late

[spaceparallax] 02/8/2006 09:33

Looks like a little more interest, presumably following the most recent RNS.

[spaceparallax] 24/7/2006 10:19

Good to see that things are progressing and that we should have some significant results in September.

[elfman] 21/7/2006 11:56

Could be lots of reasons but there seems to be no indication that the science is to blame. If the share price is down on this assumption then it simply gives a buying op IMO.
Also house broker is very upbeat on potential with 45p price target. Results of human trials in transdermal insulin will be starting to be known soon.

[hopeless698] 21/7/2006 08:13

still can't understand why Dr Ian Pattison left, especially if the companies onto such a good thing!

[ladybird1] 11/7/2006 20:23

Agree with elfman. Suggest also that it's too early to expect a reaction to the tests. Phase 1 yet to start and then Phase 2 & ultimately licencing. 18 months to 2 years away from approval. Many apparently exciting discoveries fall down in that time.

The stock is a medium/longer term investment, tho' I think safer than many in the sector.

[elfman] 11/7/2006 18:24

Who knows for sure?

Several largish funds are already in and the number of trades each day is fairly minimal. What will shift the share price will be news that interests the city. In biotechs trial results are often not as well recieved as they should be and when the momentum swings the other way the share price can be over bought. Successful trial results for the transdermal insulin should increase share price as long as an indication of potential income is given. However psg may not give the figures if they are in talks and results could then spark a licencing deal? All IMO and thinking out loud :0)

[worc0670] 11/7/2006 13:36

I'm wondering whether the gradual rise from the recent low of 9.5p is indicative of slow but sustained buying or whether its just drift..... Any opnions?

[elfman] 10/7/2006 21:45

Transdermal insulin trials are due to commence in July and as the Prof previously stated the trials in pigs give excellent indications of results.

Thought we would have seen a rise in July in anticipation of trial results.

[elfman] 04/7/2006 11:07

Great to see the big guns from Harvard getting involved. Also these trial results will be complete very quickly.

[spaceparallax] 03/7/2006 09:39

Positive progress.

[spaceparallax] 26/6/2006 11:34

If this rise continues, it helps impart a very positive upward trend over the last three months.

[elfman] 12/6/2006 11:42

Don't know AGY and PTI that well to give an opinion. PSG have some good research and results behind them. I also like their deal with Nestle, if their cholesterol lowering treatment works (similar results to Lipitor in mice studies) then they will be a takeover target IMO and Nestle may have first bite of the cherry.
Their transdermal technology is also good and the fact that they are currently extending their manufacturing facilities is also a good sign IMO.

Definately worth a look into previous RNS's and broker updates.

Like you OXB is by far my largest bio holding.

[worc0670] 10/6/2006 17:01

I've been watching AGY for the last 6 months. I nearly went in in the 70's in jan/feb but since then have felt I'd missed the boat. Thanks for reminding me though - perhaps they deserve another look.

As for PSG, I've been here for over a year now - I'd like to lower my average of 13.5p but I'm already a bit over exposed here. 2006 should be a better year for the share price I think.

cheers.

[badday] 09/6/2006 19:23

Hi Elf. No don't hold at present but do like the look of them. I only hold a few stocks at a time, usually Bio/healthcare. Currently holding just four stocks OXB being by far the largest as i'm sure you're aware. Currently looking at these, AGY, and PTI. Any views on these or the others i mentioned?

Good luck.

[elfman] 06/6/2006 15:51

badday, good to see you on board. How long have you held these?

[badday] 27/5/2006 15:47

Good presentation too. They are clearly excited about progress:

[spaceparallax] 26/5/2006 16:55

Nice to see some share price response to the good news.